OraSure Technologies | OSUR - Current Liabilities


OraSure Technologies reported $44.08M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Agilent USD 2.27B 35M Mar/2026
AngioDynamics USD 71.96M 3.68M Sep/2025
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Bio Techne USD 153.28M 12.85M Mar/2026
Bio-Rad Laboratories USD 917M 400M Mar/2026
Bruker USD 1.36B 75.9M Mar/2026
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.21B 136M Mar/2026
Dexcom USD 2.22B 81.3M Mar/2026
Illumina USD 1.57B 19M Mar/2026
Integra LifeSciences USD 346.85M 109.14M Mar/2026
Intuitive Surgical USD 2.51B 3.2M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Mettler Toledo International USD 1.11B 89.76M Mar/2026
Myriad Genetics USD 130.2M 3.6M Mar/2026
OraSure Technologies USD 44.08M 4.29M Mar/2026
Quidel USD 962.4M 3.7M Mar/2026
Repligen USD 126.21M 9.62M Mar/2026
Revvity USD 1.24B 92.6M Mar/2026
STAAR Surgical USD 60.99M 7.51M Mar/2026
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Trinity Biotech USD 141.21M 106.72M Dec/2025
Waters USD 1.24B 11.8M Dec/2025